Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cvrx Inc (CVRX)

Cvrx Inc (CVRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 258,936
  • Shares Outstanding, K 21,596
  • Annual Sales, $ 39,300 K
  • Annual Income, $ -41,200 K
  • 60-Month Beta 1.06
  • Price/Sales 6.43
  • Price/Cash Flow N/A
  • Price/Book 3.40
Trade CVRX with:

Options Overview Details

View History
  • Implied Volatility 78.46% ( +37.85%)
  • Historical Volatility 104.15%
  • IV Percentile 39%
  • IV Rank 35.49%
  • IV High 190.08% on 05/28/24
  • IV Low 17.05% on 06/07/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 29
  • Volume Avg (30-Day) 112
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,097
  • Open Int (30-Day) 1,998

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.51
  • Number of Estimates 3
  • High Estimate -0.35
  • Low Estimate -0.62
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +8.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.40 +87.34%
on 06/04/24
12.15 -1.32%
on 06/18/24
+4.61 (+62.47%)
since 05/28/24
3-Month
6.40 +87.34%
on 06/04/24
19.24 -37.68%
on 04/09/24
-6.22 (-34.16%)
since 03/28/24
52-Week
6.40 +87.34%
on 06/04/24
33.13 -63.81%
on 12/29/23
-2.74 (-18.60%)
since 06/28/23

Most Recent Stories

More News
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On

Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.

NVS : 106.46 (-0.08%)
JNJ : 146.16 (+0.25%)
LEGN : 44.29 (-0.83%)
CVRX : 11.99 (+2.48%)
PTGX : 34.65 (+8.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

CVRX : 11.99 (+2.48%)
Bronstein, Gewirtz & Grossman, LLC Notifies CVRx, Inc. (CVRX) Investors of Investigation

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). CVRx investors are encouraged...

CVRX : 11.99 (+2.48%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NYSE: CVRX). Such investors are advised...

CVRX : 11.99 (+2.48%)
CVRx to Present at the Canaccord Genuity 42nd Annual Growth Conference

MINNEAPOLIS, July 29, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and...

CVRX : 11.99 (+2.48%)
CVRx Reports Second Quarter 2022 Financial and Operating Results

Second quarter 2022 revenue of $5.0 million, a 61% increase over prior year...

CVRX : 11.99 (+2.48%)
CVRx to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call

MINNEAPOLIS, July 14, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and...

CVRX : 11.99 (+2.48%)
CVRx Launches a new Barostim™ Programmer

The new Barostim Programmer launches in the U.S., making Barostim therapy programming simpler and enabling remote view access to enhance customer support...

CVRX : 11.99 (+2.48%)
CVRx to Present at the William Blair 42nd Annual Growth Stock Conference

MINNEAPOLIS, May 23, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and...

CVRX : 11.99 (+2.48%)
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) --  CVRx, Inc. (NASDAQ:...

CVRX : 11.99 (+2.48%)

Business Summary

CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

See More

Key Turning Points

3rd Resistance Point 12.75
2nd Resistance Point 12.42
1st Resistance Point 12.20
Last Price 11.99
1st Support Level 11.65
2nd Support Level 11.32
3rd Support Level 11.10

See More

52-Week High 33.13
Fibonacci 61.8% 22.92
Fibonacci 50% 19.77
Fibonacci 38.2% 16.61
Last Price 11.99
52-Week Low 6.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar